| Amgros 2027 2.1290.b | Amgros I/S | EQL Pharma AB, Sandoz A/S, Orifarm Generics A/S, Teva Denmark A/S, Teva Denmark A/S, Sandoz A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Zentiva Denmark ApS, Zentiva Denmark ApS, Teva Denmark A/S, Strides Nordic ApS, Sandoz A/S, Strides Nordic ApS, Zentiva Denmark ApS, Sandoz A/S, Teva Denmark A/S, Zentiva Denmark ApS, Strides Nordic ApS, Zentiva Denmark ApS, Orifarm A/S, 2care4 ApS | 19.962.664 kr. | 4. november 2026 |
| Amgros 2027 2.1302.b | Amgros I/S | Macure Pharma ApS, Navamedic AB, Navamedic AB, Macure Pharma ApS, XGX Pharma ApS, Orifarm A/S, Macure Pharma ApS, Orifarm A/S, 2care4 ApS, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, Navamedic AB, Hameln Pharma ApS, Navamedic AB, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, Hameln Pharma ApS, Pfizer ApS, Orifarm A/S, MSD Danmark ApS, Hameln Pharma ApS, FrostPharma AB, Orifarm A/S, B. Braun Medical A/S, FrostPharma AB, Baxter A/S, Hameln Pharma ApS, Accord Healthcare AB, Hameln Pharma ApS, Accord Healthcare AB | 193.377.429 kr. | 29. oktober 2026 |
| Amgros 2027 2.1301.a | Amgros I/S | Macure Pharma ApS, Orifarm A/S, Macure Pharma ApS, 2care4 ApS, Macure Pharma ApS, Zambon Sweden, filial of Zambon Nederland B.V, Zambon Sweden, filial of Zambon Nederland B.V | 45.360.361 kr. | 29. oktober 2026 |
| Amgros 2027 2.290.b | Amgros I/S | Orifarm Generics A/S, Orifarm A/S, Abacus Medicine A/S, Krka Sverige AB, Zentiva Denmark ApS, Krka Sverige AB, Sandoz A/S, Orifarm Generics A/S, EQL Pharma AB, 2care4 ApS, 2care4 ApS, Abcur AB, 2care4 Generics ApS, Orifarm A/S, Abcur AB, Norgine Danmark A/S, Macure Pharma ApS, 2care4 ApS, Macure Pharma ApS, STADA Nordic ApS, Orifarm Generics A/S, 2care4 Generics ApS, 2care4 Generics ApS | 46.249.452 kr. | 25. oktober 2026 |
| Amgros 2027 2.290.b | Amgros I/S | Orifarm Generics A/S, Orifarm A/S, Abacus Medicine A/S, Krka Sverige AB, Zentiva Denmark ApS, Krka Sverige AB, Sandoz A/S, Orifarm Generics A/S, EQL Pharma AB, 2care4 ApS, 2care4 ApS, Abcur AB, 2care4 Generics ApS, Orifarm A/S, Abcur AB, Norgine Danmark A/S, Macure Pharma ApS, 2care4 ApS, Macure Pharma ApS, STADA Nordic ApS, Orifarm Generics A/S, 2care4 Generics ApS, 2care4 Generics ApS | 46.249.452 kr. | 25. oktober 2026 |
| Amgros 2027 2.290.b | Amgros I/S | Orifarm Generics A/S, Orifarm A/S, Abacus Medicine A/S, Krka Sverige AB, Zentiva Denmark ApS, Krka Sverige AB, Sandoz A/S, Orifarm Generics A/S, EQL Pharma AB, 2care4 ApS, 2care4 ApS, Abcur AB, 2care4 Generics ApS, Orifarm A/S, Abcur AB, Norgine Danmark A/S, Macure Pharma ApS, 2care4 ApS, Macure Pharma ApS, STADA Nordic ApS, Orifarm Generics A/S, 2care4 Generics ApS, 2care4 Generics ApS | 46.249.452 kr. | 25. oktober 2026 |
| Amgros 2027 2.690.b | Amgros I/S | Sandoz A/S, Accord Healthcare AB, 2care4 ApS, Sandoz A/S, Accord Healthcare AB, Sandoz A/S, Sandoz A/S, Orifarm Generics A/S, STADA Nordic ApS, Sandoz A/S, Sandoz A/S, Viatris ApS, Sandoz A/S, Teva Denmark A/S, Haleon Denmark ApS, Orifarm Generics A/S, Zentiva Denmark ApS, Medical Valley Invest AB, Krka Sverige AB, Sandoz A/S, Orifarm Generics A/S, Medical Valley Invest AB, Orifarm Generics A/S, Sandoz A/S, Mundipharma A/S, 2care4 ApS, Teva Denmark A/S, Orifarm Generics A/S, Teva Denmark A/S, Mundipharma A/S, Orifarm Generics A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag | 102.193.408 kr. | 25. oktober 2026 |
| Amgros 2027 2.690.b | Amgros I/S | Sandoz A/S, Accord Healthcare AB, 2care4 ApS, Sandoz A/S, Accord Healthcare AB, Sandoz A/S, Sandoz A/S, Orifarm Generics A/S, STADA Nordic ApS, Sandoz A/S, Sandoz A/S, Viatris ApS, Sandoz A/S, Teva Denmark A/S, Haleon Denmark ApS, Orifarm Generics A/S, Zentiva Denmark ApS, Medical Valley Invest AB, Krka Sverige AB, Sandoz A/S, Orifarm Generics A/S, Medical Valley Invest AB, Orifarm Generics A/S, Sandoz A/S, Mundipharma A/S, 2care4 ApS, Teva Denmark A/S, Orifarm Generics A/S, Teva Denmark A/S, Mundipharma A/S, Orifarm Generics A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag | 102.193.408 kr. | 25. oktober 2026 |
| Amgros 2027 2.1390.b | Amgros I/S | Orifarm A/S, Sandoz A/S, 2care4 ApS, Karo Healthcare AB, Orion Pharma A/S, Karo Healthcare AB, Orion Pharma A/S, Øresund Pharma ApS, Krka Sverige AB, 2care4 ApS, Krka Sverige AB, 2care4 ApS, Teva Denmark A/S, Teva Denmark A/S, Krka Sverige AB, Teva Denmark A/S, Krka Sverige AB, Sandoz A/S, 2care4 ApS, Krka Sverige AB, Krka Sverige AB, Orifarm A/S, 2care4 ApS | 59.180.427 kr. | 22. oktober 2026 |
| Amgros 2027 2.1390.b | Amgros I/S | Orifarm A/S, Sandoz A/S, 2care4 ApS, Karo Healthcare AB, Orion Pharma A/S, Karo Healthcare AB, Orion Pharma A/S, Øresund Pharma ApS, Krka Sverige AB, 2care4 ApS, Krka Sverige AB, 2care4 ApS, Teva Denmark A/S, Teva Denmark A/S, Krka Sverige AB, Teva Denmark A/S, Krka Sverige AB, Sandoz A/S, 2care4 ApS, Krka Sverige AB, Krka Sverige AB, Orifarm A/S, 2care4 ApS | 59.180.427 kr. | 22. oktober 2026 |
| Amgros 2027 2.1390.b | Amgros I/S | Orifarm A/S, Sandoz A/S, 2care4 ApS, Karo Healthcare AB, Orion Pharma A/S, Karo Healthcare AB, Orion Pharma A/S, Øresund Pharma ApS, Krka Sverige AB, 2care4 ApS, Krka Sverige AB, 2care4 ApS, Teva Denmark A/S, Teva Denmark A/S, Krka Sverige AB, Teva Denmark A/S, Krka Sverige AB, Sandoz A/S, 2care4 ApS, Krka Sverige AB, Krka Sverige AB, Orifarm A/S, 2care4 ApS | 59.180.427 kr. | 22. oktober 2026 |
| Amgros 2027 2.1390.b | Amgros I/S | Orifarm A/S, Sandoz A/S, 2care4 ApS, Karo Healthcare AB, Orion Pharma A/S, Karo Healthcare AB, Orion Pharma A/S, Øresund Pharma ApS, Krka Sverige AB, 2care4 ApS, Krka Sverige AB, 2care4 ApS, Teva Denmark A/S, Teva Denmark A/S, Krka Sverige AB, Teva Denmark A/S, Krka Sverige AB, Sandoz A/S, 2care4 ApS, Krka Sverige AB, Krka Sverige AB, Orifarm A/S, 2care4 ApS | 59.180.427 kr. | 22. oktober 2026 |
| Amgros 2027 2.1390.b | Amgros I/S | Orifarm A/S, Sandoz A/S, 2care4 ApS, Karo Healthcare AB, Orion Pharma A/S, Karo Healthcare AB, Orion Pharma A/S, Øresund Pharma ApS, Krka Sverige AB, 2care4 ApS, Krka Sverige AB, 2care4 ApS, Teva Denmark A/S, Teva Denmark A/S, Krka Sverige AB, Teva Denmark A/S, Krka Sverige AB, Sandoz A/S, 2care4 ApS, Krka Sverige AB, Krka Sverige AB, Orifarm A/S, 2care4 ApS | 59.180.427 kr. | 22. oktober 2026 |
| Amgros 2027 1.601.a | Amgros I/S | Unimedic Pharma AB, Abacus Medicine A/S, Orifarm A/S, Macure Pharma ApS, 2care4 ApS, 2care4 ApS, Abacus Medicine A/S, Abacus Medicine A/S, Abacus Medicine A/S | 75.178.698 kr. | 20. oktober 2026 |
| Amgros 2027 1.601.a | Amgros I/S | Unimedic Pharma AB, Abacus Medicine A/S, Orifarm A/S, Macure Pharma ApS, 2care4 ApS, 2care4 ApS, Abacus Medicine A/S, Abacus Medicine A/S, Abacus Medicine A/S | 75.178.698 kr. | 20. oktober 2026 |
| Amgros 2027 2.212.a | Amgros I/S | Orion Pharma A/S, Orion Pharma A/S, 2care4 ApS, Teva Denmark A/S, Teva Denmark A/S, 2care4 ApS, Abacus Medicine A/S, Abacus Medicine A/S, 2care4 ApS, Chiesi Pharma AB, Orion Pharma A/S, Orion Pharma A/S, Paranova Danmark A/S, 2care4 ApS, Glenmark Pharmaceuticals Nordic AB, Glenmark Pharmaceuticals Nordic AB, Glenmark Pharmaceuticals Nordic AB | 33.641.330 kr. | 13. oktober 2026 |
| Amgros 2027 2.212.a | Amgros I/S | Orion Pharma A/S, Orion Pharma A/S, 2care4 ApS, Teva Denmark A/S, Teva Denmark A/S, 2care4 ApS, Abacus Medicine A/S, Abacus Medicine A/S, 2care4 ApS, Chiesi Pharma AB, Orion Pharma A/S, Orion Pharma A/S, Paranova Danmark A/S, 2care4 ApS, Glenmark Pharmaceuticals Nordic AB, Glenmark Pharmaceuticals Nordic AB, Glenmark Pharmaceuticals Nordic AB | 33.641.330 kr. | 13. oktober 2026 |
| Amgros 2027 2.212.a | Amgros I/S | Orion Pharma A/S, Orion Pharma A/S, 2care4 ApS, Teva Denmark A/S, Teva Denmark A/S, 2care4 ApS, Abacus Medicine A/S, Abacus Medicine A/S, 2care4 ApS, Chiesi Pharma AB, Orion Pharma A/S, Orion Pharma A/S, Paranova Danmark A/S, 2care4 ApS, Glenmark Pharmaceuticals Nordic AB, Glenmark Pharmaceuticals Nordic AB, Glenmark Pharmaceuticals Nordic AB | 33.641.330 kr. | 13. oktober 2026 |
| Amgros 2027 2.212.a | Amgros I/S | Orion Pharma A/S, Orion Pharma A/S, 2care4 ApS, Teva Denmark A/S, Teva Denmark A/S, 2care4 ApS, Abacus Medicine A/S, Abacus Medicine A/S, 2care4 ApS, Chiesi Pharma AB, Orion Pharma A/S, Orion Pharma A/S, Paranova Danmark A/S, 2care4 ApS, Glenmark Pharmaceuticals Nordic AB, Glenmark Pharmaceuticals Nordic AB, Glenmark Pharmaceuticals Nordic AB | 33.641.330 kr. | 13. oktober 2026 |
| Amgros 2027 1.1203.a | Amgros I/S | Navamedic AB, Hameln Pharma ApS, Macure Pharma ApS, Hameln Pharma ApS, Orifarm A/S, 2care4 ApS, Viatris ApS, Glenmark Pharmaceuticals Nordic AB, Øresund Pharma ApS, Sandoz A/S, Orifarm A/S, Paranova Danmark A/S, Vingmed A/S, Abacus Medicine A/S, Paranova Danmark A/S | 148.085.649 kr. | 13. oktober 2026 |
| Amgros 2027 1.202.a | Amgros I/S | 2care4 ApS, Abacus Medicine A/S, Teva Denmark A/S, Macure Pharma ApS | 33.940.957 kr. | 13. oktober 2026 |
| Amgros 2027 2.1200.a | Amgros I/S | Macure Pharma ApS, Macure Pharma ApS, Macure Pharma ApS, Orifarm A/S, Orifarm A/S, Aguettant Nordic ApS, Aguettant Nordic ApS, Zentiva Denmark ApS, Aguettant Nordic ApS, Øresund Pharma ApS, Macure Pharma ApS, Orifarm A/S, Macure Pharma ApS, GE Healthcare A/S, Accord Healthcare AB, Accord Healthcare AB, Abcur AB, Paranova Danmark A/S, 2care4 ApS | 73.487.895 kr. | 13. oktober 2026 |
| Amgros 2027 2.203.b | Amgros I/S | Pfizer ApS, Pfizer ApS, Abacus Medicine A/S, Pfizer ApS, 2care4 ApS, Abacus Medicine A/S, Orifarm A/S, Pfizer ApS, 2care4 ApS, Orifarm A/S, Abacus Medicine A/S | 26.699.999 kr. | 13. oktober 2026 |
| Amgros 2027 2.203.b | Amgros I/S | Pfizer ApS, Pfizer ApS, Abacus Medicine A/S, Pfizer ApS, 2care4 ApS, Abacus Medicine A/S, Orifarm A/S, Pfizer ApS, 2care4 ApS, Orifarm A/S, Abacus Medicine A/S | 26.699.999 kr. | 13. oktober 2026 |
| Amgros 2027 1.1171.a | Amgros I/S | Bristol-Myers Squibb Denmark. Filial Af Bristol-Myers Squibb AB. Sverige, 2care4 ApS | 300.600.000 kr. | 28. september 2026 |
| Amgros 2027 1.1051.b | Amgros I/S | 2care4 ApS, Orifarm A/S, Roche Pharmaceuticals A/S | 254.000.000 kr. | 21. september 2026 |
| Amgros 2027 1.1052.b | Amgros I/S | Biocon Biologics Ireland Limited, Orion Pharma A/S, Pfizer ApS, Samsung Bioepis NL B.V., Accord Healthcare AB, Roche Pharmaceuticals A/S, Orifarm A/S, Abacus Medicine A/S, 2care4 ApS | 704.000.000 kr. | 21. september 2026 |